Lista de obras - Roger Gomis - Dominio Público Uruguay

Accurate expression profiling of very small cell populations

artículo científico publicado en 2010

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)

artículo científico publicado en 2018

C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells

artículo científico publicado en 2006

CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets

scientific article published on 19 September 2018

CLK2 blockade modulates alternative splicing compromising MYC-driven breast tumors

artículo científico publicado en 2018

Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer

artículo científico publicado en 2018

Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH.

artículo científico publicado en 2014

Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence.

artículo científico publicado en 2013

Control of glycogen deposition.

artículo científico publicado en 2003

Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice

artículo científico publicado en 2014

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

artículo científico publicado en 2017

ERK1/2 signaling induces upregulation of ANGPT2 and CXCR4 to mediate liver metastasis in colon cancer

scientific article published on 19 August 2020

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial

artículo científico publicado en 2017

Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis

artículo científico publicado en 2015

Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells

artículo científico publicado en 2012

Expression of a green fluorescence protein-carrier protein into mouse spermatozoa

artículo científico publicado en 2002

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth

artículo científico publicado en 2016

From latency to overt bone metastasis in breast cancer: potential for treatment and prevention

scientific article published on 27 June 2019

Genes that mediate breast cancer metastasis to the brain

artículo científico publicado en 2009

Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase

artículo científico publicado en 2003

HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms ⬇️

artículo científico publicado el 23 de noviembre de 2010

Identification of NOG as a specific breast cancer bone metastasis-supporting gene

artículo científico publicado en 2012

Identification of two essential glutamic acid residues in glycogen synthase

artículo científico publicado en 2000

Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer

artículo científico publicado en 2012

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

artículo científico publicado en 2017

Liver glycogen synthase but not the muscle isoform differentiates between glucose 6-phosphate produced by glucokinase or hexokinase.

artículo científico publicado en 2002

MAPK signaling control of colon cancer metastasis

artículo científico publicado en 2014

MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer

artículo científico publicado en 2018

Mammary cancer stem cells reinitiation assessment at the metastatic niche: the lung and bone.

artículo científico publicado en 2015

Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

artículo científico publicado en 2007

MiniAp-4: A Venom-Inspired Peptidomimetic for Brain Delivery

artículo científico publicado en 2015

Organ-specific metastases

artículo científico publicado en 2018

PD-L1 controls cancer pyroptosis

scientific article published on 17 September 2020

Paraspeckle factor turns TGF-β1 pro-metastatic

artículo científico publicado en 2018

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade

scientific article published on 20 January 2020

RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation

artículo científico publicado en 2014

Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α.

artículo científico publicado en 2017

Regulation of death receptor signaling by the autophagy protein TP53INP2

artículo científico publicado en 2019

Shared control of hepatic glycogen synthesis by glycogen synthase and glucokinase.

artículo científico publicado en 2000

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

artículo científico publicado en 2016

Stratification and therapeutic potential of PML in metastatic breast cancer

artículo científico publicado en 2016

Survival skills ensure that cancer spreads

artículo científico publicado en 2019

TGF-β Family Signaling in Tumor Suppression and Cancer Progression.

artículo científico publicado en 2017

TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4

artículo científico publicado en 2008

Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells

artículo científico publicado en 2018

The PP2A regulator IER5L supports prostate cancer progression

artículo científico publicado en 2024

The logic of TGFbeta signaling.

artículo científico publicado en 2006

The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.

artículo científico publicado en 2016

Tumor cell dormancy

artículo científico publicado en 2016

Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.

artículo científico publicado en 2016

Understanding the molecular mechanisms driving metastasis

artículo científico publicado en 2017

Lista de obras de Roger Gomis

Accurate expression profiling of very small cell populations

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)

C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells

CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets

CLK2 blockade modulates alternative splicing compromising MYC-driven breast tumors

Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer

Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH.

Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence.

Control of glycogen deposition.

Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

ERK1/2 signaling induces upregulation of ANGPT2 and CXCR4 to mediate liver metastasis in colon cancer

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial

Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis

Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells

Expression of a green fluorescence protein-carrier protein into mouse spermatozoa

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth

From latency to overt bone metastasis in breast cancer: potential for treatment and prevention

Genes that mediate breast cancer metastasis to the brain

Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase

HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms ⬇️

Identification of NOG as a specific breast cancer bone metastasis-supporting gene

Identification of two essential glutamic acid residues in glycogen synthase

Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

Liver glycogen synthase but not the muscle isoform differentiates between glucose 6-phosphate produced by glucokinase or hexokinase.

MAPK signaling control of colon cancer metastasis

MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer

Mammary cancer stem cells reinitiation assessment at the metastatic niche: the lung and bone.

Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

MiniAp-4: A Venom-Inspired Peptidomimetic for Brain Delivery

Organ-specific metastases

PD-L1 controls cancer pyroptosis

Paraspeckle factor turns TGF-β1 pro-metastatic

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade

RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation

Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α.

Regulation of death receptor signaling by the autophagy protein TP53INP2

Shared control of hepatic glycogen synthesis by glycogen synthase and glucokinase.

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

Stratification and therapeutic potential of PML in metastatic breast cancer

Survival skills ensure that cancer spreads

TGF-β Family Signaling in Tumor Suppression and Cancer Progression.

TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4

Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells

The PP2A regulator IER5L supports prostate cancer progression

The logic of TGFbeta signaling.

The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.

Tumor cell dormancy

Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.

Understanding the molecular mechanisms driving metastasis